146 related articles for article (PubMed ID: 17189717)
1. Role of two active site Glu residues in the molecular action of botulinum neurotoxin endopeptidase.
Kukreja RV; Sharma S; Cai S; Singh BR
Biochim Biophys Acta; 2007 Feb; 1774(2):213-22. PubMed ID: 17189717
[TBL] [Abstract][Full Text] [Related]
2. Probing the mechanistic role of glutamate residue in the zinc-binding motif of type A botulinum neurotoxin light chain.
Li L; Binz T; Niemann H; Singh BR
Biochemistry; 2000 Mar; 39(9):2399-405. PubMed ID: 10694409
[TBL] [Abstract][Full Text] [Related]
3. Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization.
Binz T; Bade S; Rummel A; Kollewe A; Alves J
Biochemistry; 2002 Feb; 41(6):1717-23. PubMed ID: 11827515
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis identifies active-site residues of the light chain of botulinum neurotoxin type A.
Rigoni M; Caccin P; Johnson EA; Montecucco C; Rossetto O
Biochem Biophys Res Commun; 2001 Nov; 288(5):1231-7. PubMed ID: 11700044
[TBL] [Abstract][Full Text] [Related]
5. Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.
Ahmed SA; Olson MA; Ludivico ML; Gilsdorf J; Smith LA
Protein J; 2008 Apr; 27(3):151-62. PubMed ID: 18213512
[TBL] [Abstract][Full Text] [Related]
6. Role of zinc binding in type A botulinum neurotoxin light chain's toxic structure.
Li L; Singh BR
Biochemistry; 2000 Aug; 39(34):10581-6. PubMed ID: 10956050
[TBL] [Abstract][Full Text] [Related]
7. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.
Rawat R; Ashraf Ahmed S; Swaminathan S
Protein Expr Purif; 2008 Aug; 60(2):165-9. PubMed ID: 18482846
[TBL] [Abstract][Full Text] [Related]
8. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
Kukreja RV; Singh BR
Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
[TBL] [Abstract][Full Text] [Related]
9. Study of asparagine 353 in aminopeptidase A: characterization of a novel motif (GXMEN) implicated in exopeptidase specificity of monozinc aminopeptidases.
Iturrioz X; Rozenfeld R; Michaud A; Corvol P; Llorens-Cortes C
Biochemistry; 2001 Dec; 40(48):14440-8. PubMed ID: 11724556
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
[TBL] [Abstract][Full Text] [Related]
11. Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme.
Agarwal R; Binz T; Swaminathan S
Biochemistry; 2005 Jun; 44(23):8291-302. PubMed ID: 15938619
[TBL] [Abstract][Full Text] [Related]
12. Zinc coordination and substrate catalysis within the neuropeptide processing enzyme endopeptidase EC 3.4.24.15. Identification of active site histidine and glutamate residues.
Cummins PM; Pabon A; Margulies EH; Glucksman MJ
J Biol Chem; 1999 Jun; 274(23):16003-9. PubMed ID: 10347149
[TBL] [Abstract][Full Text] [Related]
13. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.
Kukreja RV; Sharma SK; Singh BR
Biochemistry; 2010 Mar; 49(11):2510-9. PubMed ID: 20178376
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the catalytic domain of the Weissella oryzae botulinum-like toxin.
Košenina S; Masuyer G; Zhang S; Dong M; Stenmark P
FEBS Lett; 2019 Jun; 593(12):1403-1410. PubMed ID: 31111466
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.
Segelke B; Knapp M; Kadkhodayan S; Balhorn R; Rupp B
Proc Natl Acad Sci U S A; 2004 May; 101(18):6888-93. PubMed ID: 15107500
[TBL] [Abstract][Full Text] [Related]
18. Expression and purification of the light chain of botulinum neurotoxin A: a single mutation abolishes its cleavage of SNAP-25 and neurotoxicity after reconstitution with the heavy chain.
Zhou L; de Paiva A; Liu D; Aoki R; Dolly JO
Biochemistry; 1995 Nov; 34(46):15175-81. PubMed ID: 7578132
[TBL] [Abstract][Full Text] [Related]
19. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain.
Li L; Singh BR
Biochemistry; 2000 May; 39(21):6466-74. PubMed ID: 10828961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
